|
|
吴吉萍主任治疗肥胖型2型糖尿病医案举隅
|
Abstract:
本文为吴吉萍主任辨证论治肥胖型2型糖尿病的经验及医案浅析。吾师认为，本病主要以痰湿为病理产物，治疗应健脾化湿，清降降浊，方用二陈汤合五苓散加减方，审证求因，临床疗效佳，为后期用药提供思路。
This article is a brief analysis of Director Wu Jiping’s experience and medical case in syndrome differentiation and treatment of obese type 2 diabetes mellitus. My teacher believes that this disease is mainly based on phlegm and dampness as pathological products, and the treatment should strengthen the spleen and dispel dampness, clear and reduce turbidity and evil, the prescription uses Er Chen Tang combined with Wuling San plus or minus formula, review the evidence and seek the cause, and the clinical efficacy is good, providing ideas for the later use of drugs.
| [1] | 王海英, 刘成斌, 武杨, 等. 肥胖2型糖尿病患者血清Asprosin水平对氧化应激的影响[J]. 中国老年学杂志, 2025, 45(1): 27-29. |
| [2] | Aras, M., Tchang, B.G. and Pape, J. (2021) Obesity and Diabetes. Nursing Clinics of North America, 56, 527-541. https://doi.org/10.1016/j.cnur.2021.07.008 |
| [3] | NCD Risk Factor Collaboration (2016) Worldwide Trends in Diabetes since 1980: A Pooled Analysis of 751 Population-Based Studies with 4.4 Million Participants. The Lancet, 387, 1513-1530. |
| [4] | 谢绍锋, 黄莉吉, 曹雯, 等. 肥胖2型糖尿病的病因病机探讨[J]. 中国中医基础医学杂志, 2018, 24(7): 894-895+898. |
| [5] | 陈瑞, 张朝宁, 余臣祖, 等. 2型糖尿病合并肥胖的中医病因探讨[J]. 中医研究, 2024, 37(8): 5-7. |
| [6] | 刘建月. 现代医学对肥胖型2型糖尿病与胰岛B细胞功能关系的认识[J]. 亚太传统医药, 2009, 5(4): 116-118. |
| [7] | 冷玉琳, 印家成, 李相龙, 等. 从胰腺脏腑属性论胰腺内外分泌共病的中医证治思路[J]. 中医杂志, 2025, 66(2): 145-149+156. |
| [8] | 侯明玉, 田财军. 从痰演变过程论述二陈汤[J]. 光明中医, 2024, 39(22): 4486-4489. |
| [9] | 史周莹. 基于《黄帝内经》理论对古代中医文献中肥胖症理论及用药规律研究[D]: [硕士学位论文]. 长春: 长春中医药大学, 2023. |
| [10] | 黄展鹏, 鲍陶陶, 方朝晖, 等. 方朝晖运用五苓散加减治疗单纯性肥胖临床经验[J]. 中医药临床杂志, 2024, 36(10): 1888-1891. |
| [11] | 张宇静, 唐可伟. 以茯苓为例探讨仲景药证理论的内涵与外延[J]. 湖南中医杂志, 2021, 37(10): 132-133. |
| [12] | 王依明, 王秋红. 半夏的化学成分、药理作用及毒性研究进展[J]. 中国药房, 2020, 31(21): 2676-2682. |
| [13] | 王昌亚. 对陈皮药理作用的探讨[J]. 临床医药文献电子杂志, 2020, 7(15): 135. |
| [14] | 国家药典委员会. 中华人民共和国药典[M]. 北京: 中国医药科技出版社, 2020: 107. |
| [15] | 印家成, 富晓旭, 冷玉琳, 等. 基于数据挖掘探讨谢春光治疗2型糖尿病用药规律[J]. 中国中医药图书情报杂志, 2023, 47(6): 24-28. |
